Headline
The latest stories from AHA Today.
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., accepted the recommendation of her agency’s independent Advisory Committee on Immunization Practices to administer Pfizer’s pediatric COVID-19 vaccine to children between the ages of five and 11.
The Centers for Medicare & Medicaid Services released its calendar year 2022 final rule for the home health prospective payment system.
The Centers for Medicare & Medicaid Services issued a final rule that increases Medicare hospital outpatient prospective payment system rates by a net 2.0% in calendar year 2022 compared to 2021.
The Centers for Medicare & Medicaid Services released its calendar year 2022 final rule for the physician fee schedule.
A United States Attorney‘s Office is attempting to bootstrap the Centers for Medicare & Medicaid Services billing guidelines on overlapping surgeries into a False Claims Act case, the AHA and Hospital and Healthsystem Association of Pennsylvania argue in a friend-of-the-court brief filed in a…
AHA commented on recent Medicare Payment Advisory Commission discussions on possible approaches to reducing spending on Part B drugs and biologicals, improving alternative payment models, and revising the hospital wage index.
During an AHA-sponsored Capitol Hill briefing, hospital leaders discussed how COVID-19 has accelerated longstanding health care workforce challenges, including worker shortages and mental health fatigue.
The AHA and seven other national organizations representing hospitals and health systems urged congressional leaders to remove the reductions to the Medicaid disproportionate share hospital program and uncompensated care pools from the social spending bill known as the Build Back Better Act (H.R.…
In a study of over 89,000 adults hospitalized with COVID-19 symptoms, prior vaccination with two doses of the Pfizer or Moderna vaccine was 77% effective in preventing COVID-19 in immunocompromised patients compared with 90% effective in immunocompetent patients, the Centers for Disease Control and…
The Centers for Disease Control and Prevention’s independent Advisory Committee on Immunization Practices recommended Pfizer’s COVID-19 vaccine be administered for children ages five through 11.